This cohort study evaluated adoption rates of sodium-glucose cotransporter-2 inhibitors at US hospitals for patients with heart failure and mildly reduced or

Health ShoutOut

22.11.2024

Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction | Health ShoutOut

This cohort study evaluated adoption rates of sodium-glucose cotransporter-2 inhibitors at US hospitals for patients with heart failure and mildly reduced or

Health ShoutOut

23.11.2024

Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction | Health ShoutOut

This cohort study evaluated adoption rates of sodium-glucose cotransporter-2 inhibitors at US hospitals for patients with heart failure and mildly reduced or

Health ShoutOut

24.11.2024

Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction | Health ShoutOut

This cohort study evaluated adoption rates of sodium-glucose cotransporter-2 inhibitors at US hospitals for patients with heart failure and mildly reduced or

home›Health ShoutOut

Health ShoutOut

Health

Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction | Health ShoutOut

Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction | Health ShoutOut

Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction | Health ShoutOut

Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction | Health ShoutOut

home
›
Health ShoutOut